)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Traws Pharma
Traws Pharma (TRAW) investor relations material
Traws Pharma Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary8 May, 2026
Company overview and business model
Clinical-stage biopharmaceutical company focused on developing novel therapies for respiratory viral diseases and certain cancers.
Pipeline includes investigational antivirals for influenza, COVID-19, and multi-targeted kinase inhibitors for cancer.
Shifted focus to antivirals after a merger in April 2024, expanding from oncology to infectious diseases.
Financial performance and metrics
Audit report notes recurring losses from operations since inception, raising substantial doubt about ability to continue as a going concern.
Use of proceeds and capital allocation
Will not receive proceeds from resale of shares by selling stockholders; proceeds from warrant exercises, if any, will be used for product development and general working capital.
Management has broad discretion over use of any proceeds from warrant exercises.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Traws Pharma
- Returned to profitability in 2025 and secured up to $60M to fund key clinical milestones.TRAW
Q4 202516 Apr 2026 - Lead antivirals progress with strong data, new financing, and CEO transition for 2025 milestones.TRAWQ4 2024 & Study Update13 Feb 2026
- $128.1M H1 net loss after merger; cash runway through 2024, key clinical data ahead.TRAWQ2 20241 Feb 2026
- Registering 7.2M shares for resale, with proceeds from warrant exercises funding R&D.TRAWRegistration Filing16 Dec 2025
- 128.9M shares registered for resale post-acquisition; no proceeds to company, material risks disclosed.TRAWRegistration Filing16 Dec 2025
- Shareholders will vote on directors, incentive plan changes, executive pay, and auditor ratification.TRAWProxy Filing2 Dec 2025
- Shareholders will vote on directors, compensation, auditor ratification, and governance matters.TRAWProxy Filing2 Dec 2025
- Stockholders to vote on key proposals post-merger, including share conversion and reverse split.TRAWProxy Filing2 Dec 2025
- Stockholders will vote on key proposals supporting post-merger integration and capital flexibility.TRAWProxy Filing2 Dec 2025
Next Traws Pharma earnings date
Q1 202621 May, 2026
Traws Pharma
Next Traws Pharma earnings date
Q1 202621 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage